Gbola Amusa
Fortune : 254 500 $ au 31/08/2026
Fortune : 254 500 $ au 31/08/2026
Gbola Amusa currently works at Rainier Acquisition Corp., as Chief Executive Officer & Director from 2026, Renovacor, Inc., as Independent Director from 2021, Chardan Capital Markets LLC, as Partner from 2014, and Symbiosis Capital Management LLC, as Operating Advisor.
Dr. Amusa also formerly worked at BiomX Ltd., as Executive Chairman from 2018 to 2019, Chardan Healthcare Acquisition Corp., as Executive Chairman from 2018 to 2019, Chardan Healthcare Acquisition 2 Corp., as Executive Chairman from 2018 to 2020, BiomX, Inc., as Independent Director from 2018 to 2023, Goldman Sachs & Co. LLC, as Associate, UBS Ltd. (Broker), as Analyst from 2007 to 2013, Sanford C.
Bernstein Ltd., as Analyst, Sanford Bernstein, as Head-European Pharma Research, and Metsera, Inc., as EVP-Strategic Finance & Investor Relations.
Dr. Amusa received his undergraduate degree from Duke University, Masters Business Admin degree from The University of Chicago Booth School of Business, and doctorate degree from Washington University School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
1,16% | 27/08/2026 | 25 000 ( 1,16% ) | 254 500 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| RENOVACOR, INC. | Directeur/Membre du Conseil | 02/09/2021 |
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Directeur de la Recherche - Actions | 01/12/2014 |
Symbiosis Capital Management LLC
Symbiosis Capital Management LLC Investment ManagersFinance SymBiosis invests in both public and private companies located in the united States. The firm targets companies operating in the fields of the biotechnology. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | - |
| Sociétés | Poste | Fin |
|---|---|---|
| TESSERA DEFENSE AND HOMELAND SECURITY INC. | Directeur/Membre du Conseil | 05/01/2023 |
| CHARDAN HEALTHCARE ACQUISITION CORP | Président | 01/10/2019 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Président | 01/10/2019 |
UBS Ltd. (Broker)
UBS Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 14 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
UBS Ltd. (Broker)
UBS Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sanford C. Bernstein Ltd.
Sanford C. Bernstein Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sanford Bernstein | |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington University School of Medicine
Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
Chardan Healthcare Acquisition Corp.
Chardan Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
BiomX, Inc.
BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
Chardan Healthcare Acquisition 2 Corp.
Chardan Healthcare Acquisition 2 Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Renovacor, Inc.
Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
Symbiosis Capital Management LLC
Symbiosis Capital Management LLC Investment ManagersFinance SymBiosis invests in both public and private companies located in the united States. The firm targets companies operating in the fields of the biotechnology. It provides financing for seed, early and later stage capital requirements. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national